Anton Pekcec

2.7k total citations
53 papers, 2.1k citations indexed

About

Anton Pekcec is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Oncology. According to data from OpenAlex, Anton Pekcec has authored 53 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Cellular and Molecular Neuroscience, 16 papers in Molecular Biology and 15 papers in Oncology. Recurrent topics in Anton Pekcec's work include Neuroscience and Neuropharmacology Research (17 papers), Drug Transport and Resistance Mechanisms (13 papers) and Epilepsy research and treatment (11 papers). Anton Pekcec is often cited by papers focused on Neuroscience and Neuropharmacology Research (17 papers), Drug Transport and Resistance Mechanisms (13 papers) and Epilepsy research and treatment (11 papers). Anton Pekcec collaborates with scholars based in Germany, United States and United Kingdom. Anton Pekcec's co-authors include Heidrun Potschka, Anika M. S. Hartz, Björn Bauer, Juli Schlichtiger, David S. Miller, Jonna Soerensen, Klaus van Leyen, Emma L. B. Soldner, Kazım Yiğitkanlı and Henri Doods and has published in prestigious journals such as Nature Communications, Journal of Neuroscience and Analytical Chemistry.

In The Last Decade

Anton Pekcec

52 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anton Pekcec Germany 25 735 594 521 471 396 53 2.1k
Massimo Rizzi Italy 26 1.3k 1.8× 773 1.3× 539 1.0× 838 1.8× 625 1.6× 43 2.5k
Fiona E. Parkinson Canada 32 855 1.2× 704 1.2× 199 0.4× 298 0.6× 251 0.6× 73 2.6k
Eitan Friedman United States 29 1.1k 1.5× 1.3k 2.1× 573 1.1× 222 0.5× 138 0.3× 60 3.2k
Ralph Clinckers Belgium 24 905 1.2× 541 0.9× 110 0.2× 475 1.0× 251 0.6× 43 2.0k
Claudia Brandt Germany 32 1.7k 2.3× 734 1.2× 344 0.7× 1.6k 3.4× 879 2.2× 60 2.8k
Yilong Cui Japan 21 307 0.4× 328 0.6× 203 0.4× 179 0.4× 147 0.4× 71 1.3k
Nicholas Rensing United States 24 626 0.9× 971 1.6× 200 0.4× 367 0.8× 149 0.4× 44 2.4k
H. Jürgen Wenzel United States 24 1.4k 1.9× 1.1k 1.9× 176 0.3× 330 0.7× 207 0.5× 48 2.9k
Peter Leeds United States 27 840 1.1× 1.7k 2.8× 112 0.2× 449 1.0× 278 0.7× 29 3.0k
Ren‐Wu Chen United States 17 657 0.9× 970 1.6× 146 0.3× 386 0.8× 98 0.2× 20 2.0k

Countries citing papers authored by Anton Pekcec

Since Specialization
Citations

This map shows the geographic impact of Anton Pekcec's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anton Pekcec with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anton Pekcec more than expected).

Fields of papers citing papers by Anton Pekcec

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anton Pekcec. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anton Pekcec. The network helps show where Anton Pekcec may publish in the future.

Co-authorship network of co-authors of Anton Pekcec

This figure shows the co-authorship network connecting the top 25 collaborators of Anton Pekcec. A scholar is included among the top collaborators of Anton Pekcec based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anton Pekcec. Anton Pekcec is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Long, Fen, Tenagne D. Challa, Lianggong Ding, et al.. (2025). Glucagon controls obesity-specific energy expenditure via persistent cAMP/PKA signaling. Journal of Hepatology. 83(6). 1379–1391. 2 indexed citations
2.
Veen, Bastiaan van der, Thomas Akam, Birgit Liss, et al.. (2023). Control of sustained attention and impulsivity by Gq-protein signalling in parvalbumin interneurons of the anterior cingulate cortex. Translational Psychiatry. 13(1). 243–243. 8 indexed citations
3.
Nasseri, Saeed, et al.. (2023). Triple-tyrosine kinase inhibition by BIBF1000 attenuates airway and pulmonary arterial remodeling following chronic allergen challenges in mice. European journal of medical research. 28(1). 71–71. 2 indexed citations
4.
5.
Reboll, Marc R., Mortimer Korf‐Klingebiel, Priyanka Gupta, et al.. (2019). Crystal structure and receptor-interacting residues of MYDGF — a protein mediating ischemic tissue repair. Nature Communications. 10(1). 5379–5379. 21 indexed citations
6.
Ursu, Daniel, Bastiaan van der Veen, Birgit Liss, et al.. (2019). Pharmacokinetic and pharmacodynamic actions of clozapine-N-oxide, clozapine, and compound 21 in DREADD-based chemogenetics in mice. Scientific Reports. 9(1). 4522–4522. 187 indexed citations
7.
8.
Dalley, Jeffrey W., et al.. (2018). Differences in trait impulsivity do not bias the response to pharmacological drug challenge in the rat five-choice serial reaction time task. Psychopharmacology. 235(4). 1199–1209. 15 indexed citations
9.
10.
Pekcec, Anton, et al.. (2015). Dissociable effects of mGluR5 allosteric modulation on distinct forms of impulsivity in rats: interaction with NMDA receptor antagonism. Psychopharmacology. 232(18). 3327–3344. 30 indexed citations
11.
Fougère, Christian la, Guoming Xiong, Juli Schlichtiger, et al.. (2010). Imaging of P‐glycoprotein–mediated pharmacoresistance in the hippocampus: Proof‐of‐concept in a chronic rat model of temporal lobe epilepsy. Epilepsia. 51(9). 1780–1790. 37 indexed citations
12.
Pekcec, Anton, Matthias Lüpke, Rolf Baumann, H. Seifert, & Heidrun Potschka. (2010). Modulation of neurogenesis by targeted hippocampal irradiation fails to affect kindling progression. Hippocampus. 21(8). 866–876. 29 indexed citations
13.
Pekcec, Anton, et al.. (2009). Age-dependent decline of blood–brain barrier P-glycoprotein expression in the canine brain. Neurobiology of Aging. 32(8). 1477–1485. 20 indexed citations
14.
Soerensen, Jonna, et al.. (2009). Pyrrolidine dithiocarbamate protects the piriform cortex in the pilocarpine status epilepticus model. Epilepsy Research. 87(2-3). 177–183. 10 indexed citations
15.
Pekcec, Anton, et al.. (2009). Prevention of seizure-induced up-regulation of endothelial P-glycoprotein by COX-2 inhibition. Neuropharmacology. 56(5). 849–855. 108 indexed citations
16.
Vliet, Erwin A. van, Anton Pekcec, Juli Schlichtiger, et al.. (2009). COX-2 inhibition controls P-glycoprotein expression and promotes brain delivery of phenytoin in chronic epileptic rats. Neuropharmacology. 58(2). 404–412. 116 indexed citations
17.
Pekcec, Anton, Wolfgang Baumgärtner, Jens P. Bankstahl, Veronika M. Stein, & Heidrun Potschka. (2008). Effect of aging on neurogenesis in the canine brain. Aging Cell. 7(3). 368–374. 51 indexed citations
18.
Bauer, Björn, et al.. (2007). Seizure-Induced Up-Regulation of P-Glycoprotein at the Blood-Brain Barrier through Glutamate and Cyclooxygenase-2 Signaling. Molecular Pharmacology. 73(5). 1444–1453. 217 indexed citations
19.
Potschka, Heidrun, Anton Pekcec, Birgit Weinhold, & Rita Gerardy‐Schahn. (2007). Deficiency of neural cell adhesion molecule or its polysialylation modulates pharmacological effects of the AMPA receptor antagonist NBQX. Neuroscience. 152(4). 1093–1098. 7 indexed citations
20.
Pekcec, Anton, Wolfgang Lo ̈scher, & Heidrun Potschka. (2006). Neurogenesis in the adult rat piriform cortex. Neuroreport. 17(6). 571–574. 76 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Massimo Rizzi Breakdown of academic impact, for papers by Fiona E. Parkinson Breakdown of academic impact, for papers by Eitan Friedman Breakdown of academic impact, for papers by Ralph Clinckers Breakdown of academic impact, for papers by Claudia Brandt Breakdown of academic impact, for papers by Yilong Cui Breakdown of academic impact, for papers by Nicholas Rensing Breakdown of academic impact, for papers by H. Jürgen Wenzel Breakdown of academic impact, for papers by Peter Leeds Breakdown of academic impact, for papers by Ren‐Wu Chen
Rankless by CCL
2026